Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: Association with clinical and MRI activity

Journal of Neuroimmunology

Volumn 126, Issue 1-2, 2002, Pages 143-160

  Hellings, Niels ^a,b   Gelin, Geert ^c   Medaer, Robert ^a   Bruckers, Liesbeth ^a   Palmers, Yvan ^a,c   Raus, Jef ^a,b   Stinissen, Piet ^a,d  

^a HASSELT UNIVERSITY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d Universitaire Campus Gebouw A   (Belgium)

Author keywords

Adhesion molecules; Cytokines; ELISPOT; MRI; Multiple sclerosis; Myelin reactive T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MYELIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE EXACERBATION; DOWN REGULATION; EVALUATION; FEMALE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; LONGITUDINAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECURRENT DISEASE; REGULATORY MECHANISM; T LYMPHOCYTE;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-6; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN BASIC PROTEINS; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036096668     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00052-8     Document Type: Article

References (54)

1. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis
2. T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice
3. Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein
4. Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis
5. T cell receptor V beta gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosis
6. CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis
7. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
8. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: Correlation with clinical activity
9. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS
10. Circulating adhesion molecules and inflammatory mediators in demyelination: A review
11. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging
12. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
13. Insights into the immunopathogenesis of multiple sclerosis
14. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals
15. Tumor necrosis factor identified in multiple sclerosis brain
16. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group [see comments]
17. Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis
18. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
19. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE
20. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis
21. Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis
22. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
23. Preparation of proteolipids
24. Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis
25. 2+ influx in patients with relapsing-remitting multiple sclerosis
26. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones
27. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force
28. Review: Cytokines and the pathogenesis of multiple sclerosis
29. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis
30. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis
31. Multiple sclerosis: In relapsing patients, immune functions vary with disease activity as assessed by MRI
32. B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: Dependency on local IL-6 production
33. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity
34. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis
35. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis
36. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis
37. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
38. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation
39. A cell culture model for T lymphocyte clonal anergy
40. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
41. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions
42. Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid
43. Biological markers in body fluids for activity and progression in multiple sclerosis
44. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse
45. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
46. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration
47. Diversity and plasticity of self recognition during the development of multiple sclerosis
48. Dynamics of the reactivity to MBP in multiple sclerosis
49. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: Restricted T cell receptor V gene rearrangements and CDR3 sequence
50. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis
51. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients
52. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity
53. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
54. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression [In Process Citation]